NCT02201030View on ClinicalTrials.gov

Immunogenicity and Safety Study of NBP606 in Healthy Infants

PHASE3CompletedINTERVENTIONAL
Enrollment

577

Participants

Timeline

Start Date

September 6, 2014

Primary Completion Date

October 21, 2016

Study Completion Date

October 21, 2016

Conditions
Pneumococcal Infections
Interventions
BIOLOGICAL

NBP606

A single intramuscular injection into the thigh

BIOLOGICAL

Prevnar13

A single intramuscular injection into the thigh

Trial Locations (1)

Unknown

Confidential, Seoul

All Listed Sponsors
lead

SK Chemicals Co., Ltd.

INDUSTRY

NCT02201030 - Immunogenicity and Safety Study of NBP606 in Healthy Infants | Biotech Hunter | Biotech Hunter